Dr Reddys Laboratories Share Price Today - Live Blog for July 18, 2025

Dr Reddys Laboratories Ltd's share price rallied by 0.29%, reaching the current market price of ₹1,259.05. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.21%, a situation worth noting. At present, the stock is trading at ₹1,257.90. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6400, while the industry PE ratio is 35.9007.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.06%, with its current market value per share resting at ₹1,260.75. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price has dropped by -0.00%, a development that warrants careful analysis. Presently trading at ₹1,259.95, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.06% upswing and is currently trading at ₹1,260.00, indicating strong market sentiment.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% decline, and it currently trades at ₹1,259.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.10% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,259.35. The stock is currently trading at a PE of 18.6400, while the industry PE is 35.9007, prompting investors to assess its value proposition.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.12% increase and currently trading at ₹1,260.60 per share. This upward trajectory is turning heads in the market.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,259.70. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.6400, while the industry PE is 35.9007.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.00%, reaching the current market price of ₹1,260.00. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.13% increase and currently trading at ₹1,259.00 per share. This upward trajectory is turning heads in the market.

The share price of Dr Reddys Laboratories Ltd experienced a -0.06% slump and is currently trading at ₹1,257.35. While the stock maintains a PE ratio of 18.6400, the industry PE is 35.9007, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price rallied by 0.06%, reaching the current market price of ₹1,258.40. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.07% decline, and it currently trades at ₹1,255.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,255.20, and market participants are assessing the implications. The stock has a PE ratio of 18.6400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.10% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,256.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.10%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,253.75, and market participants are assessing the implications. The stock has a PE ratio of 18.6400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.06% uptick in its share price. As a result, it's now actively trading at ₹1,255.00 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.16%, reaching a current market price of ₹1,256.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd experienced a -0.16% downturn in its share price, and it's currently trading at ₹1,256.00. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,256.00. The stock is currently trading at a PE of 18.6400, while the industry PE is 35.9007, prompting investors to assess its value proposition.

Demonstrating a commendable 0.04% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,261.95. In terms of valuation, the stock maintains a PE ratio of 18.6400, while the industry PE ratio stands at 35.9007.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.04% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,261.95 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.25%, and it's currently trading at ₹1,260.80. The stock maintains a PE of 18.6400, while the industry PE is 35.9007, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd stock price decreased by -0.16%, with the current market value at ₹1,263.90 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's shares experienced a 0.14% uptick, and they are currently valued at ₹1,265.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.